Author:
de Leval Laurence,Foss Francine,Gaulard Philippe
Reference90 articles.
1. Frizzera G, Moran E, Rappaport H. Angio-immunoblastic lymphadenopathy with dysproteinemia. Lancet. 1974;1:1070–3.
2. Lukes RJ, Tindle BH. Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin’s disease. N Engl J Med. 1975;292:1–8.
3. Lennert K. [Nature, prognosis and nomenclature of angioimmunoblastic lymphadenopathy (lymphogranulomatosis X or T-zone lymphoma)]. Dtsch Med Wochenschr. 1979;104:1246–7.
4. Shimoyama M, Minato K. [Clinical, cytological and immunological analysis of T-cell type lymphoid malignancies: a classification of T-cell type lymphoid malignancy (author’s transl)]. Rinsho Ketsueki. 1979;20:1056–69.
5. Feller AC, Griesser H, Schilling CV, et al. Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy. Am J Pathol. 1988;133:549–56.